2023 Incentive Grant Recipient: Savannah Correll, PharmD
Project Proposal: Providing Community Pharmacists with the Tools to Identify “Red Flags” in Stimulant Prescribing Behaviors
Savannah Correll, PharmD, currently serves as the PGY-1 Community-Based Pharmacy Resident at Albertsons Companies in Portland, Oregon.
With the start of the COVID-19 public health emergency, the DEA changed the policies regarding controlled substances to where authorized practitioners can now prescribe a controlled substance to a patient without an in-person medical evaluation. Since this change in policy, community pharmacies have experienced an increase in stimulant prescriptions, especially from telehealth companies. Pharmacists play a critical role as the last line in patients’ safety; it is important for them to have the proper education and tools to enforce these high safety standards.
Savannah is excited to have the opportunity to further educate pharmacists with the training she has created. The grant will allow her to provide incentives to encourage more people to participate and learn how they can help reduce stimulant misuse and abuse.